BARINTHUS BIOTHERAPEUTICS PLC Interest Expense
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) reported Interest Expense of $12.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-13.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-13
- BARINTHUS BIOTHERAPEUTICS PLC interest expense for the quarter ending 2024-03-31 was $12.00K.
- BARINTHUS BIOTHERAPEUTICS PLC interest expense for the quarter ending 2023-12-31 was $7.00K.
- BARINTHUS BIOTHERAPEUTICS PLC interest expense for the quarter ending 2023-09-30 was $7.00K.
- BARINTHUS BIOTHERAPEUTICS PLC interest expense for the quarter ending 2023-06-30 was $14.00K.
- BARINTHUS BIOTHERAPEUTICS PLC interest expense for fiscal 2023 was $28.00K, a 47.37% increase from fiscal 2022.
- BARINTHUS BIOTHERAPEUTICS PLC interest expense for fiscal 2022 was $19.00K, a 99.29% decline from fiscal 2021.
- BARINTHUS BIOTHERAPEUTICS PLC interest expense for fiscal 2021 was $2.67M, a 25.89% decline from fiscal 2020.
- BARINTHUS BIOTHERAPEUTICS PLC interest expense for fiscal 2020 was $3.60M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $12.00K 10-Q · filed 2024-05-13 | $19.00K derived: sum of 2 quarters · filed 2024-05-13 | $26.00K derived: sum of 3 quarters · filed 2024-05-13 | $40.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $14.00K derived: sum of 2 quarters · filed 2024-03-20 | $28.00K derived: sum of 3 quarters · filed 2024-03-20 | $28.00K 10-K · filed 2024-03-20 |
| 2023-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $21.00K derived: sum of 2 quarters · filed 2023-11-09 | $21.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $14.00K 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | $19.00K 10-K · filed 2024-03-20 | |||
| 2022-03-31 | $74.00K 10-Q · filed 2023-05-12 | $92.00K derived: sum of 2 quarters · filed 2023-05-12 | $92.00K derived: sum of 3 quarters · filed 2023-05-12 | $92.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $18.00K derived: sum of 2 quarters · filed 2023-03-24 | $18.00K derived: sum of 3 quarters · filed 2023-03-24 | $2.67M 10-K · filed 2023-03-24 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $2.65M 10-Q · filed 2021-11-12 | $5.28M derived: sum of 4 quarters · filed 2022-05-11 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.65M 10-Q · filed 2021-08-12 | $5.28M derived: sum of 3 quarters · filed 2022-05-11 | $6.25M derived: sum of 4 quarters · filed 2022-05-11 |
| 2021-03-31 | $2.65M 10-Q · filed 2022-05-11 | $5.28M derived: sum of 2 quarters · filed 2022-05-11 | $6.25M derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $3.60M derived: sum of 2 quarters · filed 2022-03-25 | $3.60M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $969.00K 10-Q · filed 2021-11-12 | $969.00K 10-Q · filed 2021-11-12 |